While EGFR or ALK oncogenic alterations are more often reported in Asian patients with NSCLC [35], MET alterations such as METex14 generally appear to be less prevalent in Asian versus Caucasian patients [4,36,37]. Here, ALK is linked to non-small cell lung carcinoma.